A viral inhibitor of peptide transporters for antigen presentation - PDF document

Aug 20, 2022 •384 likes •441 views

See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/15438128 A viral inhibitor of peptide transporters for antigen presentation Article in Nature July 1995 DOI: 10.1038/375415a0

See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/15438128 A viral inhibitor of peptide transporters for antigen presentation Article in Nature · July 1995 DOI: 10.1038/375415a0 · Source: PubMed CITATIONS READS 553 183 8 authors , including: Klaus Früh Hakim Djaballah Oregon Health and Science University Keren Therapeutics, New York, United States 189 PUBLICATIONS 11,686 CITATIONS 126 PUBLICATIONS 3,045 CITATIONS SEE PROFILE SEE PROFILE Robert Tampé Pete Peterson Goethe-Universität Frankfurt am Main Northwood University, cedar Hill, TX 358 PUBLICATIONS 14,812 CITATIONS 102 PUBLICATIONS 11,800 CITATIONS SEE PROFILE SEE PROFILE Some of the authors of this publication are also working on these related projects: Membrane biophysics View project Dementias View project All content following this page was uploaded by Hakim Djaballah on 21 May 2014. The user has requested enhancement of the downloaded file.
View publication stats View publication stats

Recommend

Peptide Antigen Display and Recognition: a New Fusion of Genomics and Proteomics? T-cell antigen

Peptide Antigen Display and Recognition: a New Fusion of Genomics and Proteomics? T-cell antigen recognition Motivation We are on the brink of learning to control critical aspects of the immune system in a very specific manner Accuracy

496 views • 10 slides

GSZ 10 5 10 15 20 0 5 off on A11_mel A12_mel A1_mel A2_mel A3_mel A4_mel

GSZ 10 5 10 15 20 0 5 off on A11_mel A12_mel A1_mel A2_mel A3_mel A4_mel A7_mel A8_mel B12_mel B1_mel B2_mel B6_mel B7_mel C12_mel antigen processing and presentation of exogenous peptide antigen via MHC class II

457 views • 3 slides

Analysis of the Signal Peptide dataset November 28, 2019 1 Signal Peptide - A short peptide

Analysis of the Signal Peptide dataset November 28, 2019 1 Signal Peptide - A short peptide (typically 15-30 residues long), destined towards the secretory pathway - Cleaved during translocation across membrane existing in all 3 kingdoms of

365 views • 21 slides

antigen igen distri stribu bution ion in placen acenta ta and d fetuse ses Estela

Yellow ow feve ver immun uniza ization ion dur uring ing preg egnan nancy cy A mo mous use model del: : gestat station onal al perf rform ormance ance and d viral ral antigen igen distri stribu bution ion in placen

1.23k views • 22 slides

Cholesterol transporters Cholesterol transporters as new therapeutic targets as new therapeutic

Cholesterol transporters Cholesterol transporters as new therapeutic targets as new therapeutic targets Unit de Pharmacologie F. Van Bambeke cellulaire et molculaire Physiological roles of cholesterol Physical role: structure and

701 views • 36 slides

Antigen Antigen Effector uptake presentation function Protein antigens are processed by

CD4+ helper T lymphocyte response Antigen Antigen Effector uptake presentation function Protein antigens are processed by antigen presenting cells and E f f e c t o r C D 4 + h e l p e r T peptides associated with HLA class lymphocytes

412 views • 8 slides

Molecular mechanisms of ABC multidrug transporters transporters and beyond Ion-coupled ABC

23/10/2012 Our studies on molecular mechanisms of Molecular mechanisms of ABC multidrug transporters transporters and beyond Ion-coupled ABC exporters exporters PatAB LmrP H E N D R I K W . V A N V E E N D E P A R T M E N T O F

173 views • 4 slides

L14 Mass Spec Quantitation MS applications Microarray analysis CSE182 LC-MS Maps Peptide 2 I

L14 Mass Spec Quantitation MS applications Microarray analysis CSE182 LC-MS Maps Peptide 2 I Peptide 1 m/z time A peptide/feature can be labeled with the triple Peptide 2 elution (M,T,I): x x x x monoisotopic M/Z, centroid x x x

861 views • 51 slides

Prediction of HIV viral tropism based on NGS data Nico Pfeifer Max Planck Institute for

Prediction of HIV viral tropism based on NGS data Nico Pfeifer Max Planck Institute for Informatics Cell entry Wu et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists Science 19 November 2010: 330

448 views • 33 slides

BI 201335, a NS3/4A Serine Protease Inhibitor, and BI 207127, a NNI NS5b Polymerase Inhibitor for

BI 201335, a NS3/4A Serine Protease Inhibitor, and BI 207127, a NNI NS5b Polymerase Inhibitor for treatment of chronic HCV infection Wulf Otto Bcher Boehringer Ingelheim Pharma, Biberach, Germany NS3/4A Protease Inhibitor BI 201335 Chemical

629 views • 15 slides

Peptide modeling in isolation and in interaction : steps towards rational peptide design Pierre

Peptide modeling in isolation and in interaction : steps towards rational peptide design Pierre Tuffry GT MASIM Paris, 17 novembre 2017 Equipe 1 : "Structure-based peptide design" (Dr P. Tuffery) Equipe 2 : "Computational

704 views • 49 slides

The Food Act 2014 Food Safety requirements for growers, processors, transporters and

The Food Act 2014 Food Safety requirements for growers, processors, transporters and manufacturers Hemp Industry Liaison Group, March 2019 Food Act 2014: A Flexible Risk Based Approach Growers and Transporters = NP1 Growing and minimal

252 views • 12 slides

Membrane Transporters in Drug Development Dr Raymond Evers Merck & Co Drug Metabolism and

Membrane Transporters in Drug Development Dr Raymond Evers Merck & Co Drug Metabolism and Pharmacokinetics P.O. Box 2000 Rahway, NJ 08816 Raymond_Evers@merck.com Outline Part 1 Overview of the ITC Transporters covered by the

745 views • 49 slides

Session Viral Hepatitis B & D: Clinical Saturday April 25, 2015 Cihan Yurdaydin, MD 1

Session Viral Hepatitis B & D: Clinical Saturday April 25, 2015 Cihan Yurdaydin, MD 1 2 Optimizing the prenylation inhibitor lonafarnib using ritonavir boosting in patients with chronic delta hepatitis Cihan Yurdaydin, Ramazan

490 views • 29 slides

Antigen Processing and Presentation Chapter 8 Antigen Recognition by T Cells T cells

Antigen Processing and Presentation Chapter 8 Antigen Recognition by T Cells T cells recognize linear peptides not whole proteins. T cells only recognize epitopes when they are complexed to MHC molecules. Therefore protein

548 views • 43 slides

Antigen Effector Antigen uptake function presentation Dendritic cells process protein

CD8+ cytotoxic T lymphocyte response Antigen Effector Antigen uptake function presentation Dendritic cells process protein antigens and display antigenic peptides associated with HLA class I receptors to CD8+ cytotoxic T lymphocytes in

301 views • 7 slides

GP IIB/IIIA Inhibitor Use During GP IIB/IIIA Inhibitor Use During Endovascular Intervention

GP IIB/IIIA Inhibitor Use During GP IIB/IIIA Inhibitor Use During Endovascular Intervention Endovascular Intervention Jay S. Yadav M.D. Director, Vascular Intervention Dept of Cardiovascular Medicine The Cleveland Clinic Foundation Name: Jay

1.03k views • 44 slides

Antigen processing and presentation Requirement for Antigen Presenting Cells (APCs) Properties

Antigen processing and presentation Requirement for Antigen Presenting Cells (APCs) Properties and functions of APCs Functions of different APCs Dendritic cell - T cell interactions Human Dendritic Cells Routes of antigen entry Maturation of

596 views • 21 slides

FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T

1 Antigen Presenting Cells, Antigen Presentation, T Lymphocyte Activation Abul K. Abbas UCSF FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T cell activation Costimulation, the B7:CD28

954 views • 28 slides

HPPD-inhibitor resistance stewardship: The perspective of the HRAC HPPD- inhibitor Working Group

2014 WSSA Vancouver, British Columbia HPPD-inhibitor resistance stewardship: The perspective of the HRAC HPPD- inhibitor Working Group Gordon D. Vail 1 , Roland S. Beffa 2 , William L. Patzoldt 3 , Peter J. Porpiglia 4 and Walter E. Thomas 5

543 views • 16 slides

Algorithms in Bioinformatics: A f Practical Introduction Practical Introduction Peptide

Algorithms in Bioinformatics: A f Practical Introduction Practical Introduction Peptide Sequencing Peptide Sequencing What is Peptide Sequencing? g High-throughput Protein Sequencing is to deduce the amino acid sequence of a d d h i

669 views • 53 slides

Antigen Antibody Reactions The interactions between antigens and antibodies are known as

Antigen Antibody Reactions The interactions between antigens and antibodies are known as antigen antibody reactions . The reactions are highly specific, and an antigen reacts only with antibodies produced by itself or with closely

122 views • 8 slides

Viral Hepatitis Surveillance in Tennessee NASTAD Viral Hepatitis TA Meeting November 29, 2017

Viral Hepatitis Surveillance in Tennessee NASTAD Viral Hepatitis TA Meeting November 29, 2017 Lindsey Sizemore, Viral Hepatitis Program Director Turning of The Tides HIV Risk Vulnerability Assessment Webinar (CDC, September 2, 2015)

470 views • 28 slides

Viral Shedding Viral Shedding <in hospital> <in hospital> into Patients' ??? ???

ICH WORKSHOP: Viral Shedding Review of experience of shedding data for in vivo gene therapy Teruhide YAMAGUCHI Viral Shedding Viral Shedding <in hospital> <in hospital> into Patients' ??? ??? Blood, Urine, Gene Therapy

342 views • 6 slides